These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31599762)

  • 1. Linking innate immunity and chronic antibody-mediated allograft rejection.
    Gill RG; Lin CM
    Curr Opin Organ Transplant; 2019 Dec; 24(6):694-698. PubMed ID: 31599762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.
    Zhang H; Li Z; Li W
    Front Immunol; 2021; 12():648539. PubMed ID: 33815407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in allograft vasculopathy.
    Merola J; Jane-Wit DD; Pober JS
    Curr Opin Organ Transplant; 2017 Feb; 22(1):1-7. PubMed ID: 27898462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic allograft dysfunction: a model disorder of innate immunity.
    Land WG
    Biomed J; 2013; 36(5):209-28. PubMed ID: 24225188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cells: Critical Effectors During Antibody-mediated Rejection of Solid Organ Allografts.
    Miyairi S; Baldwin WM; Valujskikh A; Fairchild RL
    Transplantation; 2021 Feb; 105(2):284-290. PubMed ID: 32384380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive features of innate immune cells and their relevance to graft rejection.
    Wang G; Kong G; Li XC
    Curr Opin Organ Transplant; 2019 Dec; 24(6):664-669. PubMed ID: 31577598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
    Sicard A; Meas-Yedid V; Rabeyrin M; Koenig A; Ducreux S; Dijoud F; Hervieu V; Badet L; Morelon E; Olivo-Marin JC; Dubois V; Thaunat O
    Kidney Int; 2017 Jul; 92(1):214-226. PubMed ID: 28318622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity in ischemia-reperfusion injury and graft rejection.
    Nakamura K; Kageyama S; Kupiec-Weglinski JW
    Curr Opin Organ Transplant; 2019 Dec; 24(6):687-693. PubMed ID: 31592839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity and cardiac allograft rejection.
    Millington TM; Madsen JC
    Kidney Int Suppl; 2010 Dec; (119):S18-21. PubMed ID: 21116311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
    Lee H; Min JW; Kim JI; Moon IS; Park KH; Yang CW; Chung BH; Oh EJ
    Medicine (Baltimore); 2016 Mar; 95(11):e3094. PubMed ID: 26986147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.
    Baldwin WM; Valujskikh A; Fairchild RL
    Curr Opin Organ Transplant; 2016 Feb; 21(1):7-14. PubMed ID: 26575854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The many shades of macrophages in regulating transplant outcome.
    Chen S; Lakkis FG; Li XC
    Cell Immunol; 2020 Mar; 349():104064. PubMed ID: 32061375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of HMGB1 in heart transplantation.
    Lv Q; Li C; Mo Y; He L
    Immunol Lett; 2018 Feb; 194():1-3. PubMed ID: 29198620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
    Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Frydas I; Theoharides TC
    Inflamm Res; 2018 Sep; 67(9):747-755. PubMed ID: 29961151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The innate NK cells, allograft rejection, and a key role for IL-15.
    Kroemer A; Xiao X; Degauque N; Edtinger K; Wei H; Demirci G; Li XC
    J Immunol; 2008 Jun; 180(12):7818-26. PubMed ID: 18523245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors, innate immunity and lung transplantation.
    Snyder LD; Palmer SM
    Front Biosci (Elite Ed); 2009 Jun; 1(2):600-4. PubMed ID: 19482676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral Response in Liver Allograft Transplantation: A Review of the Role of Anti-Human Leukocyte Antigen (HLA) Antibodies.
    Muro M; Moya-Quiles MR; Mrowiec A
    Curr Protein Pept Sci; 2016; 17(8):776-784. PubMed ID: 26916161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.